The OncLive® Conference page includes a listing of all conferences covered by OncLive®, including the ASCO, ESMO, SITC, EHA, ASH, and SABCS annual meetings, as well as the Chemotherapy Foundation Symposium and Miami Breast Cancer Conference, among many others. Conference coverage incorporates articles and interviews in written and video format.
April 12th 2011, 5:56am
Interdisciplinary Prostate Cancer Congress
Screening for prostate cancer does work, despite controversy about its efficacy, according to IPCC Co-chair Leonard G. Gomella
April 11th 2011, 12:12pm
Interdisciplinary Prostate Cancer Congress
Hormonal therapies have long been the standard of care for metastatic advanced prostate cancer
April 11th 2011, 12:03pm
Interdisciplinary Prostate Cancer Congress
As research into novel vaccine approaches for treating advanced prostate cancer continues...
April 11th 2011, 11:59am
Interdisciplinary Prostate Cancer Congress
Increased prostate cancer screening has led to overtreatment and has not significantly reduced mortality rates in prostate cancer
March 18th 2011, 2:04pm
PER® Miami Breast Cancer Conference
In this podcast, Maisam Fazel, FRCS, MS, MB BChir, discusses his research into a checklist for breast cancer surgeons.
March 16th 2011, 12:25pm
PER® Miami Breast Cancer Conference
Dr. Daniel Osman, director of the Miami Breast Cancer Conference, on Designing the Program for the MBCC
March 14th 2011, 1:56pm
PER® Miami Breast Cancer Conference
Maisam Fazel, FRCS, MS, MB BChir, of Imperial College Healthcare NHS Trust in the United Kingdom on Trends in Surgical Training
March 14th 2011, 5:08am
PER® Miami Breast Cancer Conference
As the number of breast cancer survivors grows, so does the emphasis on establishing individualized survivorship plans
March 14th 2011, 5:07am
PER® Miami Breast Cancer Conference
Preoperative neoadjuvant systemic therapy can be valuable for patients even if they do not achieve a pathologic complete response
March 14th 2011, 5:04am
PER® Miami Breast Cancer Conference
With thousands of clinical trials in play, many oncology specialists are reluctant to embrace findings from newly-released studies
March 14th 2011, 5:02am
PER® Miami Breast Cancer Conference
Should genomic profiles be used routinely to determine which breast cancer patients receive adjuvant chemotherapy
March 14th 2011, 5:00am
PER® Miami Breast Cancer Conference
Personalized treatment in oncology is a popular concept these days, but the goal remains elusive
March 11th 2011, 10:00am
PER® Miami Breast Cancer Conference
It is time to rethink the way oncologists in the United States are treating ductal carcinoma in situ
March 11th 2011, 9:59am
PER® Miami Breast Cancer Conference
The addition of sorafenib to capecitabine as a first-line therapy for patients with advanced breast cancer
March 10th 2011, 4:20pm
PER® Miami Breast Cancer Conference
Daniel A. Osman, MD, Founder and Course Director of the Miami Breast Cancer Conference Discusses Methods for Detecting Malignant Conditions in Breast Cancer
March 10th 2011, 2:30pm
PER® Miami Breast Cancer Conference
The climate for medical malpractice litigation in breast cancer treatment seems to be worsening
March 10th 2011, 2:27pm
PER® Miami Breast Cancer Conference
Breast pain is among the most common reasons that women seek medical attention from a breast specialist.
March 10th 2011, 11:57am